Peetz Christopher 4
4 · Mirum Pharmaceuticals, Inc. · Filed Aug 12, 2025
Insider Transaction Report
Form 4
Peetz Christopher
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2025-08-11−40,000→ 158,487 totalExercise: $2.94Exp: 2029-03-11→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2025-08-11$2.94/sh+40,000$117,440→ 178,641 total - Sale
Common Stock
2025-08-11$62.00/sh−40,000$2,480,000→ 138,641 total
Holdings
- 208,570(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 22, 2024.
- [F2]The stock option is fully vested.